-
1 Comment
Eckert & Ziegler Strahlen- und Medizintechnik AG is currently in a long term uptrend where the price is trading 58.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.3.
Eckert & Ziegler Strahlen- und Medizintechnik AG's total revenue sank by 4.5% to $43M since the same quarter in the previous year.
Its net income has increased by 55.0% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 43.3% to $16M since the same quarter in the previous year.
Based on the above factors, Eckert & Ziegler Strahlen- und Medizintechnik AG gets an overall score of 4/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | DE0005659700 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Beta | 1.5 |
|---|---|
| Market Cap | 1B |
| PE Ratio | 27.8 |
| Target Price | 66 |
| Dividend Yield | 0.8% |
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EUZ.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
